Abstract
Pharmacogenomics in the treatment of parkinson�??s disease.
Chandrima Saha.
Parkinson's sickness (PD) is the second most normal neurodegenerative problem with expanding proof of hereditary factor adding to its etiology. Accessibility of successful pharmacological treatment recognizes it from other neurodegenerative issues. The nigrostriatal dopaminergic pathway is the objective for the majority of the accessible treatments.For suggestive alleviation L-dopa in mix with carbidopa is the medication of decision separated from which dopamine agonists (DAs), catecol-O-methyltransferase (COMT) inhibitors and monoamine oxidase inhibitors are different medications.
Manuscript Submission
Submit your manuscript at Online Submission System
Google scholar citation report
Citations : 1101
International Journal of Pharmacy received 1101 citations as per google scholar report
International Journal of Pharmacy peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- HINARI
- Index Copernicus
- Google Scholar
- The Global Impact Factor (GIF)
- Polish Scholarly Bibliography (PBN)
- Cosmos IF
- Open Academic Journals Index (OAJI)
- Directory of Research Journal Indexing (DRJI)
- EBSCO A-Z
- OCLC- WorldCat
- MIAR
- International committee of medical journals editors (ICMJE)
- Scientific Indexing Services (SIS)
- Scientific Journal Impact Factor (SJIF)
- Euro Pub
- Eurasian Scientific Journal Index
- Root indexing
- International Institute of Organized Research
- InfoBase Index
- International Innovative Journal Impact Factor
- J-Gate